No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
Background: Platelet-activating factor (PAF) seems to be implicated in systemic lupus erythematosus (SLE) patients with associated renal diseases.Aims: In this study, we ensured the role of PAF in SLE patients without renal complications.
Main Authors: | Yves Denizot, Eric Liozon, Laurence Guglielmi, Kim Ly, Pascale Soria, Véronique Loustaud, Elisabeth Vidal, Marie Odile Jauberteau |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2003-01-01
|
Series: | Mediators of Inflammation |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/0962935031000097718 |
Similar Items
-
Incidence of psoriasis in patients with active systemic lupus erythematosus
by: Mansoor Karimifar, et al.
Published: (2020-01-01) -
Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity
by: Tim Dierckx, et al.
Published: (2020-03-01) -
Pregnancy in Systemic Lupus Erythematosus Patients with Nephritis
by: Panagiotis Pateinakis, et al.
Published: (2014-07-01) -
The role of Dickkopf-1 as a biomarker in systemic lupus erythematosus and active lupus nephritis
by: Mervat E. Abdelazeem, et al.
Published: (2021-03-01) -
Influence of prolactin and estrogen on disease activity in patients with systemic lupus erythematosus
by: Marwa Mahmoud Abdelaziz, et al.
Published: (2018-01-01)